Access to Clinical Trials
You may benefit from participating in our clinical trials, which have evaluated a variety of novel therapies, including the effectiveness of certain medications to improve metabolism and decrease inflammation or liver scarring, as well as new ways to diagnose liver disease. As part of the Nonalcoholic Steatohepatitis (NASH) Clinical Research Network, we offer you the opportunity to participate in treatment studies that may test new therapies for nonalcoholic fatty liver disease and cirrhosis.
National Leaders in Liver Research
You benefit from information collected by us and other researchers that highlights promising treatments. Additionally, the NASH Network directs research on treating nonalcoholic fatty liver disease, which is often associated with obesity or a family history of liver disease.
Experts in the Latest Diagnostic Tool
We were involved in the research and development of FibroScan and were one of the first medical centers to offer this noninvasive alternative to liver biopsy. It uses ultrasound to evaluate the stiffness of the liver, which may indicate liver fibrosis (scarring) or cirrhosis.